Monoclonal antibody to a human MDR1 multidrug resistance gene pr

Details Monoclonal antibody to a human MDR1 multidrug resistance gene pr Monoclonal antibody to a human MDR1 multidrug resistance gene pr

1992-03-20

1995-07-18

Lacey, David L.

Chemistry: molecular biology and microbiology

Spore forming or isolating process

53038885, 5303888, 5303871, 5303873, 4353201, 4241561, 4241421, G12N 518, C09K 1528, C12N 1500

Patent

active

054340756

ABSTRACT:
A hybridoma (termed "UIC2 hybridoma", ATCC Accession No. HB11207) producing monoclonal antibodies (termed "UIC2 mAb") directed against an extracellular domain of a cell surface P-glycoprotein antigen associated with multidrug resistance in primate cells was produced by fusing a human myeloma cell with a spleen cell derived from a BALB/c mouse immunized with syngeneic 3T3 fibroblasts previously transfected with the isolated human mdr1 cDNA. UIC2 mAb, thus produced, as well as fragments and recombinant derivatives thereof, may be used to detect and isolate multidrug resistant primate cells and human mdr1 gene products, and to reverse multidrug resistance in primate cells, including cells of multidrug resistant human tumors.

REFERENCES:
patent: 4918163 (1990-04-01), Young et al.
patent: 5057598 (1991-10-01), Pollack et al.
patent: 5091513 (1992-02-01), Huston et al.
patent: 5130127 (1992-07-01), Herlyn
patent: 5134075 (1992-07-01), Hellstrom et al.
patent: 5204095 (1993-04-01), Goodall et al.
patent: 5215913 (1993-06-01), Posner
Lazar et al., Molecular and Cellular Biology, 8(3) 1247, 1988.
Burgess et al., Journal of Cell Biology, 111:2129, 1990.
Hird et al., Genes and Cancer, 1990.
McCaffetry et al., Nature, 348, 1990, 553.
Thorpe, Monoclonal and Antibodies, 84, 1985, 475-506.
Shen et al., Molecular and Cellular Biology, vol. 6, 4039, 1986.
Kuwazura et al., Cancer, 66(5), 1990, 868.
Meyers et al., Cancer Research 49:3209-3214, 1989.
Hamada et al., PNAS 7785, vol. 83, 1986.
Waldmann, Science, 252, 1657, 1991.
Tao et al., J. Immunology, 143, 2595, 1989.
P. A. Trail et al., Science, 261:212-215 (1993).
M. Sung Co et al., Nature, 351:501-502 (1991).
Hamada, H., et al., PNAS (USA) 83:7785 (1986).
Meyers, M. B., et al., Cancer Res., 49:3209 (1989).
O'Brien, J. P., et al., Proc. Amer. Assoc. Cancer Res., 30:Abs. 2114 (1989).
Tsuruo, T., et al., Jpn. J. Cancer Res., 80:627 (1989).
Rittman-Grauer, L., Proc. Amer. Assoc. Cancer Res., 31:Abs. 2663 (1990).
Hamada, H., et al., Cancer Res., 50:3167 (1990).
Georges, E., et al., Amer. Assoc. Cancer Res., Poster Session A (1991).
Cenciarelli, C., et al., Int. J. Cancer, 47:533 (1991).
Pearson, J. W., et al., J. Nat'l Cancer Inst., 88:1386 (1991).
Mechetner, E. B., and I. B. Roninson, Proc. Natl. Acad. Sci. USA, 89:5824-5828 (1992).

Affiliated with

Also associated with

Rating

Monoclonal antibody to a human MDR1 multidrug resistance gene pr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibody to a human MDR1 multidrug resistance gene pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody to a human MDR1 multidrug resistance gene pr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2418864